Earnings release
Page 1
Page 1 of 4 Press Release Ad hoc announcement pursuant to Art. 53 LR Altstätten, 31 July 2026 COLTENE publishes results for the first half of 2026 COLTENE Holding AG, a leading international developer and manufacturer of dental consumables and small equipment, generated sales of CHF 112.8 million in the first half of 2026, an increase of 0.8% in local currencies and −4.4% in the reporting currency. The EMEA region and the Infection Control business unit in particular recorded strong growth. The EBIT margin reached 5.1%, mainly reflecting the lower gross margin, while further cost reductions partly offset the negative impact on earnings. For the second half of the year, COLTENE expects an improvement in performance and confirms its outlook for the 2026 financial year. Resilient market with varying dynamics Demand in the market remained fundamentally intact in the first half of the year, although momentum varied across regions and product areas. Compared with the previous year, COLTENE achieved sales growth of 0.8% in local currency. Negative currency effects, however, weighed on reported sales (−5.2%). Product launches in the Infection Control business unit were very well received by the market, whereas geopolitical developments, temporary destocking in the US, and local events in Latin America led to a more cautious market environment and delays in orders. These effects were particularly noticeable in regions where dental procedures are not covered by insurance and where larger investments by dental practices were involved. Positive signs are emerging for the second half of the year. Product areas: innovations provide positive momentum The Infection Control business unit increased sales by 4.9% in local currency (−3.2% in CHF). Although higher-priced equipment continued to be ordered cautiously, surface disinfection and instrument washers including cleaning solutions grew significantly above the market in the double-digit percentage range. This was driven in particular by recent launches such as the HYDRIM 112W instrument washer. The Dental Preservation business unit recorded sales 1.0% lower in local currency (−4.9% in CHF). Product launches such as the CalciSeal root canal sealer were positively received, and the OGSF file sequence continued to deliver above-average growth. However, the business unit was affected by a significant inventory reduction by a major distributor in the US. The business unit Treatment Auxiliaries was also affected by this inventory reduction and recorded a decline of 1.5% in local currency (−5.2% in CHF). DACH region with strong sales development, delays in North and Latin America North America, COLTENE’s largest region by sales, accounted for 46.4% of revenue (H1 2025: 48.3%). Sales in local currency were at the previous year’s level (−0.3%). However, currency effects additionally reduced sales by 8.0%. Sales were supported by the launch of the HYDRIM 112W instrument washer and by the surface disinfection area with products from the OPTIM family. Order delays for consumables due to inventory optimizations are expected to lead to higher demand in the second half of the year. EMEA (Europe, Middle East and Africa) developed strongly, with growth in local currency of 6.8% (5.5% in CHF). Its share of sales rose to 38.1% (H1 2025: 34.5%). DACH and Benelux were the
Page 2
Page 2 of 4 key growth regions. Asia’s share declined to 10.0% (H1 2025: 11.0%), with sales down 7.3% in local currency (−13.3% in CHF), due to a challenging market situation in China and a timing effect for individual large orders in Japan. India, by contrast, showed strong development. Latin America recorded a sales decline of 9.9% in local currency (−13.9% in CHF), with its share of group sales at 5.5%. In individual markets, political uncertainties at the beginning of the year led to order delays, which are expected to be recovered in the second half of the year. Higher material and logistics costs, strict operating cost management The gross margin reached 65.0% (H1 2025: 66.4%). The change was mainly due to adverse foreign currency developments, partly higher material and logistics costs as a result of higher energy prices, and an unfavourable product mix. Operating result (EBIT) amounted to CHF 5.8 million, with an EBIT margin of 5.1% (H1 2025: 6.4%). The lower EBIT was mainly attributable to the lower gross margin, although cost reductions under the Operational Excellence program partly offset the negative effect of gross profit. Consolidated net profit reached CHF 4.1 million (previous year: CHF 4.3 million). Free cash flow improved significantly to CHF 4.8 million from CHF −0.3 million in the previous year, driven by a higher operating cash flow (CHF 7.6 million versus CHF 1.6 million in the previous year) due to the improvement in net working capital. Strengthening of Group Management To implement its strategy, COLTENE has aligned Group Management with the next development steps. Effective 1 May 2026, Brandon Arsenault was appointed Chief Commercial Officer for Sales and Marketing Communications North America. Patrick Bayer will assume the role of Chief Marketing Officer as of 1 September 2026 and will be responsible for the global marketing activities of the COLTENE Group. This will strengthen market execution in North America and advance the implementation of the Group’s priorities. Outlook – improved order momentum COLTENE expects demand to pick up in the second half of the year. Positive signals were already evident in June, with noticeably improved order momentum. Inventory adjustments in North America are expected to result in a recovery of demand in the second half of the year, while an improving political environment in Latin America is also anticipated to support growth. At the margin level, COLTENE expects positive momentum despite ongoing currency headwinds, driven by higher sales volumes, a more favorable product mix, and the benefits of measures implemented to offset increased energy costs. For the full year, COLTENE expects a slight increase in sales and an improvement in profitability, assuming constant exchange rates. In the medium term, COLTENE confirms its communicated targets of 3–5% organic sales growth and an EBIT margin of 13−15%. Half-year report 2026 The half-year report is available at invest.coltene.com/financial-publications/business-reports/.
Page 3
Page 3 of 4 Key figures in CHF 1 000 H1 2026 H1 2025 Change in % Net sales 112 808 118 052 -4.4% Operating expenses 63 959 67 573 -5.3% Operating result (EBIT) 5 753 7 527 -23.6% in % of net sales 5.1% 6.4% Net profit 4 051 4 265 -5.0% Cash flow from operating activities 7 550 1 588 375.5% Investments (net) -2 742 -1 839 49.1% Free cash flow 4 808 -251 in CHF 1 000 30.06.26 30.06.25 Change in % Net debt -33 350 -34 554 -3.5% Total assets 188 586 177 218 6.4% Shareholder’s equity 93 264 90 432 3.1% in % of total assets 49.5% 51.0% Number of employees (FTE) 1 137 1 176 -3.3% Contact Investor Relations Markus Abderhalden, CFO Phone +41 71 757 54 80 Mobile +41 79 436 26 22 E-Mail markus.abderhalden@coltene.com To receive regular updates on COLTENE Holding AG, please register at invest.coltene.com. Financial calendar Release of key figures 2026 15 January 2027 Release of full-year report and Media and analysts’ conference on the annual results 2026 5 March 2027 Annual General Meeting 2027 21 April 2027 Release of the half-year report and Media and analysts’ conference on the half-year results 2027 30 July 2027 About COLTENE COLTENE is an international developer, manufacturer, and seller of dental consumables and small equipment in the areas of Infection Control, Dental Improvement, and Treatment Auxiliaries. COLTENE has state-of-the-art production facilities in the USA, Canada, Germany, France, Hungary and Switzerland as well as own sales organizations in all major markets including Europe, North and Latin America, Japan, China and India. Dentists, DSOs, dental clinics, and dental labs all around the globe trust COLTENE’s high-quality products. The registered shares of COLTENE Holding AG (CLTN) are listed on SIX Swiss Exchange. Learn more about COLTENE and its products at www.coltene.com.
Page 4
Page 4 of 4 Contact COLTENE Holding AG Feldwiesenstrasse 20 CH-9450 Altstätten T + 41 71 757 53 00 investor@coltene.com www.coltene.com This written statement and oral statements or other statements made, or to be made, by us contain forward-looking statements that do not relate solely to historical or current facts. These forward-looking statements are based on the current plans and expectations of our management and are subject to a number of uncertainties and risks that could significantly affect our current plans and expectations, as well as future results of operations and financial conditions. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.